Abstract:
From Time Dependent Intermittent Self-Catheterization
to Volume Dependent Self-Catheterization in Multiple
Sclerosis using the PCI 5000 BladderManager®
D.
De Ridder, H. Van Poppel, L. Baert, and J. Binard. "From
time dependent intermittent self-catheterisation to
volume dependent self-catheterisation in Multiple Sclerosis
using the PCI 5000 BladderManager®."
Spinal Cord 35 (1997): 613-16.
Objectives:
* To assess the accuracy of the BladderManager®
PCI 5000, and the viability of replacing time-dependent
self-catheterization programs for multiple sclerosis
patients with a volume-dependent self-catheterization
program using the PCI 5000.
Methods:
* Twenty-five multiple sclerosis patients participated
in the study. All had previously been on an intermittent
self-catheterization program. Before use of the BladderManager®
commenced, a record of voiding and catheterization time
and volume, and periods of incontinence, was kept for
48 hours for each patient. Then, for a period of two
weeks, the patients were allowed to use the BladderManager®,
after having been trained in a one to two hour session.
Ultrasound measurements were performed by patients every
hour during the day and every two hours during the night.
A pre-set volume was calculated at which each patient
should void, and when the BladderManager®
indicated that this volume had been reached, the patient
was catheterized. After two weeks, ultrasound volumes
and catheterized volume measurements were recorded on
a voiding chart over a period of two days, and this
chart was compared to the voiding chart made prior to
the introduction of the BladderManager®.
* The number of catheterizations, catheterized volume,
and periods of incontinence were the variables used
to assess the possible benefits of patient and volume
controlled catheterization.
Results:
* Evaluation of ultrasound measurements showed an accuracy
of 91.05%.
* After ultrasound measurement was introduced, the average
catheterized volume for the study group increased from
260.8 cc ± 154.5 cc (median = 245 cc) to 297.5
cc ± 138.9 cc (median = 316 cc).
* The frequency of catheterization was diminished after
the introduction of the BladderManager®.
* The number of incontinent periods for the whole group,
measured during 48 hours, was decreased from 69 to 39
(P < 0.05) under the volume-dependent program.
* Independence of bladder control increased in more
than half of the patients with the use of the BladderManager®.
Conclusions:
* "There is little doubt that the PCI 5000 BladderManager®
is accurate enough to be used in a clinical setting.
The correlation between catheterized and measured volume
as well as the accuracy are excellent for an ultrasound
measurement."
* "This ultrasound unit can be used in a reliable
way by patients or nurses without any ultrasound experience,
after an initial training of less than two hours."
* With the PCI 5000, the number of incontinent episodes
was reduced, which improved patients' quality of life
and reduced the cost of care by decreasing the need
for incontinence supplies.
* The PCI 5000 is of value as a feedback training device
for multiple sclerosis patients. "Using the PCI
5000 BladderManager® we were able to
improve the urological status even in these patients
[who were in advanced state of multiple sclerosis],
proving that even in advanced stages biofeedback training
techniques can be useful. This is very important from
the rehabilitation point of view, since it improves
the self esteem of the patient, decreases his incontinence
and consequent social problems, without increasing the
level of assistance needed, thus increasing the quality
of life."
If
you would like to read this study, please contact
us and we will send a copy to you. |